+1 347 708 0418
PD-L1 Biomarker Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global PD-L1 Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
PD-L1 IHC 22C3 Assay
PD-L1 IHC 28-8 Assay
PD-L1 (SP142) Assay
PD-L1 (SP263) Assay
Segment by Application
Hospital
Diagnostic Center
Others
By Company
Agilent Technologies
Eli Lilly
AstraZeneca
Roche
Bristol-Myers Squibb
Merck
Pfizer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PD-L1 IHC 22C3 Assay
1.2.3 PD-L1 IHC 28-8 Assay
1.2.4 PD-L1 (SP142) Assay
1.2.5 PD-L1 (SP263) Assay
1.3 Market by Application
1.3.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 Biomarker Testing Market Perspective (2017-2028)
2.2 PD-L1 Biomarker Testing Growth Trends by Region
2.2.1 PD-L1 Biomarker Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 PD-L1 Biomarker Testing Historic Market Size by Region (2017-2022)
2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Region (2023-2028)
2.3 PD-L1 Biomarker Testing Market Dynamics
2.3.1 PD-L1 Biomarker Testing Industry Trends
2.3.2 PD-L1 Biomarker Testing Market Drivers
2.3.3 PD-L1 Biomarker Testing Market Challenges
2.3.4 PD-L1 Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PD-L1 Biomarker Testing Players by Revenue
3.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2017-2022)
3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2017-2022)
3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue
3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio
3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2021
3.5 PD-L1 Biomarker Testing Key Players Head office and Area Served
3.6 Key Players PD-L1 Biomarker Testing Product Solution and Service
3.7 Date of Enter into PD-L1 Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 Biomarker Testing Breakdown Data by Type
4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2017-2022)
4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2023-2028)
5 PD-L1 Biomarker Testing Breakdown Data by Application
5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2017-2022)
5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America PD-L1 Biomarker Testing Market Size (2017-2028)
6.2 North America PD-L1 Biomarker Testing Market Size by Type
6.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2017-2022)
6.2.2 North America PD-L1 Biomarker Testing Market Size by Type (2023-2028)
6.2.3 North America PD-L1 Biomarker Testing Market Share by Type (2017-2028)
6.3 North America PD-L1 Biomarker Testing Market Size by Application
6.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2017-2022)
6.3.2 North America PD-L1 Biomarker Testing Market Size by Application (2023-2028)
6.3.3 North America PD-L1 Biomarker Testing Market Share by Application (2017-2028)
6.4 North America PD-L1 Biomarker Testing Market Size by Country
6.4.1 North America PD-L1 Biomarker Testing Market Size by Country (2017-2022)
6.4.2 North America PD-L1 Biomarker Testing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe PD-L1 Biomarker Testing Market Size (2017-2028)
7.2 Europe PD-L1 Biomarker Testing Market Size by Type
7.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2017-2022)
7.2.2 Europe PD-L1 Biomarker Testing Market Size by Type (2023-2028)
7.2.3 Europe PD-L1 Biomarker Testing Market Share by Type (2017-2028)
7.3 Europe PD-L1 Biomarker Testing Market Size by Application
7.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2017-2022)
7.3.2 Europe PD-L1 Biomarker Testing Market Size by Application (2023-2028)
7.3.3 Europe PD-L1 Biomarker Testing Market Share by Application (2017-2028)
7.4 Europe PD-L1 Biomarker Testing Market Size by Country
7.4.1 Europe PD-L1 Biomarker Testing Market Size by Country (2017-2022)
7.4.2 Europe PD-L1 Biomarker Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PD-L1 Biomarker Testing Market Size (2017-2028)
8.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific PD-L1 Biomarker Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific PD-L1 Biomarker Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America PD-L1 Biomarker Testing Market Size (2017-2028)
9.2 Latin America PD-L1 Biomarker Testing Market Size by Type
9.2.1 Latin America PD-L1 Biomarker Testing Market Size by Type (2017-2022)
9.2.2 Latin America PD-L1 Biomarker Testing Market Size by Type (2023-2028)
9.2.3 Latin America PD-L1 Biomarker Testing Market Share by Type (2017-2028)
9.3 Latin America PD-L1 Biomarker Testing Market Size by Application
9.3.1 Latin America PD-L1 Biomarker Testing Market Size by Application (2017-2022)
9.3.2 Latin America PD-L1 Biomarker Testing Market Size by Application (2023-2028)
9.3.3 Latin America PD-L1 Biomarker Testing Market Share by Application (2017-2028)
9.4 Latin America PD-L1 Biomarker Testing Market Size by Country
9.4.1 Latin America PD-L1 Biomarker Testing Market Size by Country (2017-2022)
9.4.2 Latin America PD-L1 Biomarker Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PD-L1 Biomarker Testing Market Size (2017-2028)
10.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa PD-L1 Biomarker Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa PD-L1 Biomarker Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.1.5 Agilent Technologies Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly PD-L1 Biomarker Testing Introduction
11.2.4 Eli Lilly Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.2.5 Eli Lilly Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca PD-L1 Biomarker Testing Introduction
11.3.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.3.5 AstraZeneca Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche PD-L1 Biomarker Testing Introduction
11.4.4 Roche Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.4.5 Roche Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction
11.5.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck PD-L1 Biomarker Testing Introduction
11.6.4 Merck Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer PD-L1 Biomarker Testing Introduction
11.7.4 Pfizer Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.7.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of PD-L1 IHC 22C3 Assay
Table 3. Key Players of PD-L1 IHC 28-8 Assay
Table 4. Key Players of PD-L1 (SP142) Assay
Table 5. Key Players of PD-L1 (SP263) Assay
Table 6. Global PD-L1 Biomarker Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global PD-L1 Biomarker Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global PD-L1 Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global PD-L1 Biomarker Testing Market Share by Region (2017-2022)
Table 10. Global PD-L1 Biomarker Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global PD-L1 Biomarker Testing Market Share by Region (2023-2028)
Table 12. PD-L1 Biomarker Testing Market Trends
Table 13. PD-L1 Biomarker Testing Market Drivers
Table 14. PD-L1 Biomarker Testing Market Challenges
Table 15. PD-L1 Biomarker Testing Market Restraints
Table 16. Global PD-L1 Biomarker Testing Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global PD-L1 Biomarker Testing Revenue Share by Players (2017-2022)
Table 18. Global Top PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2021)
Table 19. Ranking of Global Top PD-L1 Biomarker Testing Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players PD-L1 Biomarker Testing Product Solution and Service
Table 23. Date of Enter into PD-L1 Biomarker Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2017-2022)
Table 27. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2023-2028)
Table 29. Global PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global PD-L1 Biomarker Testing Revenue Share by Application (2017-2022)
Table 31. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global PD-L1 Biomarker Testing Revenue Share by Application (2023-2028)
Table 33. North America PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific PD-L1 Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific PD-L1 Biomarker Testing Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 63. Agilent Technologies Company Details
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies PD-L1 Biomarker Testing Product
Table 66. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 67. Agilent Technologies Recent Developments
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly PD-L1 Biomarker Testing Product
Table 71. Eli Lilly Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 72. Eli Lilly Recent Developments
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca PD-L1 Biomarker Testing Product
Table 76. AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 77. AstraZeneca Recent Developments
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche PD-L1 Biomarker Testing Product
Table 81. Roche Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 82. Roche Recent Developments
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb PD-L1 Biomarker Testing Product
Table 86. Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Developments
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck PD-L1 Biomarker Testing Product
Table 91. Merck Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 92. Merck Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer PD-L1 Biomarker Testing Product
Table 96. Pfizer Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 97. Pfizer Recent Developments
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-L1 Biomarker Testing Market Share by Type: 2021 VS 2028
Figure 2. PD-L1 IHC 22C3 Assay Features
Figure 3. PD-L1 IHC 28-8 Assay Features
Figure 4. PD-L1 (SP142) Assay Features
Figure 5. PD-L1 (SP263) Assay Features
Figure 6. Global PD-L1 Biomarker Testing Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Diagnostic Center Case Studies
Figure 9. Others Case Studies
Figure 10. PD-L1 Biomarker Testing Report Years Considered
Figure 11. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global PD-L1 Biomarker Testing Market Share by Region: 2021 VS 2028
Figure 14. Global PD-L1 Biomarker Testing Market Share by Players in 2021
Figure 15. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2021
Figure 17. North America PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 19. North America PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 20. North America PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
Figure 21. United States PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 25. Europe PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 26. Europe PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
Figure 27. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific PD-L1 Biomarker Testing Market Size Share by Region (2017-2028)
Figure 37. China PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 45. Latin America PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 46. Latin America PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
Figure 47. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
Figure 53. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 57. Eli Lilly Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 58. AstraZeneca Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 59. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 61. Merck Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 62. Pfizer Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Buy
